Grindeks

About Grindeks

JSC "Grindeks" is a vertically integrated pharmaceutical company based in Riga, the Baltics,  with the history from 1946. Its main fields of action are research, development, manufacturing and sales of original products, generics and active pharmaceutical ingredients. The company specializes in the heart and cardiovascular, CNS and anti-cancer medication therapeutic groups. 

Certifications
  • Country/Region:
    Latvia
  • On CPHI since:
    2015
  • Certificates:
    2
  • Employees:
    1000 - 4999
Company types
CMO/CDMO
Contract Service
Generics/Biosimilars Manufacturer
Pharmaceutical company
Contact info

Products from Grindeks (3)

  • Grindeks API portfolio

    Product Grindeks API portfolio

    Please see Grindeks up-to-date Active Pharmaceutical Ingredient (API) product portfolio in the link attached: https://grindeks.com/en/products/active-pharmaceutical-ingredients/
  • Grindeks FDF portfolio

    Product Grindeks FDF portfolio

    Please see Grindeks up-to-date Final Dosage Form (FDF) product portfolio, including pipeline products, in the link attached. Dossiers are harmonized according to ICH and EMA requirements. https://grindeks.com/en/products/final-dosage-forms/
  • Fentanyl

Grindeks Resources (1)

  • Brochure Grindeks Group CDMO

    Grindeks provides a wide range of development, analytical, and manufacturing services to support all stages of API and Final dosage form development – from early stages to GMP production.